Company intelligence / Profile preview
Octane Biotherapeutics
Kingston, Ontario, Canada
- Ownership
- Private
- Development stage
- Other
01
Overview
Octane Biotherapeutics offers the Novocart platform (Novocart 3D and Novocart Inject), regenerative cartilage implants with a strong clinical history in Germany and Switzerland. Production is being transitioned from manual to automated using the Cocoon system. More than 30,000 patients have been treated in Europe; clinical trials underway in the US.[3]
- Therapeutic areas
- Rheumatology
- Modalities
- Cell therapyBiologicHydrogel-based drug delivery therapyMatrix implantRecombinant protein
- Industry
- Biotech
02
Drug pipeline
2 assets1 more asset in the full pipeline.
Request access →03
Partnerships
LonzaB. Braun (via acquisition of orthobiologics business)
Beyond the preview
Go deeper on Octane Biotherapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Octane Biotherapeutics.